Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 1
2015 1
2017 2
2020 4
2021 3
2022 3
2023 7
2024 19
2025 27
2026 29

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
Antiphospholipid antibodies and cardiovascular thrombosis.
Rashedi S, Leyva H, Siddiqui SA, Bukhari S, Pfeferman MB, Watson NW, Ujueta F, Zarghami M, Bacare B, Kanthi Y, Jimenez D, Monreal M, Siegal DM, Barnes GD, Eikelboom JW, O'Donoghue ML, Ruff CT, Galli M, Weber BN, Goldhaber SZ, Uljon S, Middeldorp S, Lopes RD, Garcia DA, Lip GYH, Weitz JI, Connors JM, Krumholz HM, Knight JS, Lippi G, Elkind MSV, Cushman M, Costenbader KH, Piazza G, Bikdeli B. Rashedi S, et al. Among authors: weber bn. Nat Rev Cardiol. 2026 Mar 10. doi: 10.1038/s41569-026-01269-9. Online ahead of print. Nat Rev Cardiol. 2026. PMID: 41807758 Review.
Fueling the Fire: Autoimmunity and Atherosclerosis.
Weber BN, Blankstein R. Weber BN, et al. J Am Coll Cardiol. 2024 Jun 25;83(25):2655-2657. doi: 10.1016/j.jacc.2024.04.031. J Am Coll Cardiol. 2024. PMID: 38897675 Free PMC article. No abstract available.
Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular Disease.
Berman AN, Biery DW, Besser SA, Singh A, Shiyovich A, Weber BN, Huck DM, Divakaran S, Hainer J, Kaur G, Blaha MJ, Cannon CP, Plutzky J, Januzzi JL, Booth JN 3rd, López JAG, Kent ST, Nasir K, Di Carli MF, Bhatt DL, Blankstein R. Berman AN, et al. Among authors: weber bn. J Am Coll Cardiol. 2024 Mar 5;83(9):873-886. doi: 10.1016/j.jacc.2023.12.031. J Am Coll Cardiol. 2024. PMID: 38418000 Free PMC article.
Therapeutic management of inflammatory heart diseases.
Bonaventura A, Del Buono MG, Golino M, Potere N, Vecchié A, Malandrino D, Van Tassell B, Youngstein T, Weber BN, Abbate A. Bonaventura A, et al. Among authors: weber bn. Pharmacol Ther. 2026 Apr;280:108996. doi: 10.1016/j.pharmthera.2026.108996. Epub 2026 Jan 30. Pharmacol Ther. 2026. PMID: 41621731 Review.
Intensive Lowering of LDL Cholesterol Levels With Evolocumab in Autoimmune or Inflammatory Diseases: An Analysis of the FOURIER Trial.
Zimerman A, Kunzler ALF, Weber BN, Ran X, Murphy SA, Wang H, Honarpour N, Keech AC, Sever PS, Sabatine MS, Giugliano RP. Zimerman A, et al. Among authors: weber bn. Circulation. 2025 May 20;151(20):1467-1476. doi: 10.1161/CIRCULATIONAHA.124.072756. Epub 2025 Apr 21. Circulation. 2025. PMID: 40255182 Free PMC article. Clinical Trial.
94 results